Build Your Comparison

Side-by-side financial analysis
CYN logo
CYN
LIDR logo
LIDR
RBOT logo
RBOT
IROQ logo
IROQ
ZVIA logo
ZVIA
KO logo
KO
JPM logo
JPM
Try popular comparisons:

Stock Comparison

CYN vs LIDR vs RBOT vs IROQ vs ZVIA vs KO vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CYN
Cyngn Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$14M
5Y Perf.-100.0%
LIDR
AEye, Inc.

Auto - Parts

Consumer CyclicalNASDAQ • US
Market Cap$74M
5Y Perf.-99.0%
RBOT
Vicarious Surgical Inc.

Medical - Devices

HealthcareNYSE • US
Market Cap$3M
5Y Perf.-99.9%
IROQ
IF Bancorp, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$89M
5Y Perf.+23.2%
ZVIA
Zevia PBC

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$100M
5Y Perf.-86.8%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$355.61B
5Y Perf.+46.6%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+88.8%

CYN vs LIDR vs RBOT vs IROQ vs ZVIA vs KO vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CYN logoCYN
LIDR logoLIDR
RBOT logoRBOT
IROQ logoIROQ
ZVIA logoZVIA
KO logoKO
JPM logoJPM
IndustrySoftware - ApplicationAuto - PartsMedical - DevicesBanks - RegionalBeverages - Non-AlcoholicBeverages - Non-AlcoholicBanks - Diversified
Market Cap$14M$74M$3M$89M$100M$355.61B$896.00B
Revenue (TTM)$276K$270K$0.00$48M$169M$49.28B$280.33B
Net Income (TTM)$-26M$-34M$-42M$5M$-7M$13.70B$57.05B
Gross Margin34.4%-144.1%59.5%47.1%61.7%60.0%
Operating Margin-99.2%-125.8%14.9%-3.3%29.3%25.9%
Forward P/E19.4x25.3x14.4x
Total Debt$7M$235K$8M$73M$668K$45.49B$942.38B
Cash & Equiv.$990K$43M$3M$20M$25M$10.27B$343.34B

CYN vs LIDR vs RBOT vs IROQ vs ZVIA vs KO vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CYN
LIDR
RBOT
IROQ
ZVIA
KO
JPM
StockOct 21Jun 26Return
Cyngn Inc. (CYN)1000.0-100.0%
AEye, Inc. (LIDR)1001.0-99.0%
Vicarious Surgical … (RBOT)1000.1-99.9%
IF Bancorp, Inc. (IROQ)100123.2+23.2%
Zevia PBC (ZVIA)10013.2-86.8%
The Coca-Cola Compa… (KO)100146.6+46.6%
JPMorgan Chase & Co. (JPM)100188.8+88.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: CYN vs LIDR vs RBOT vs IROQ vs ZVIA vs KO vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: KO leads in 3 of 7 categories (7-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. AEye, Inc. is the stronger pick specifically for recent price momentum and sentiment. RBOT, ZVIA, and JPM also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇KO emerged as the overall leader. Track its performance:
CYN
Cyngn Inc.
The Technology Pick

CYN doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.

Best for: technology exposure
LIDR
AEye, Inc.
The Growth Play

LIDR is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 15.3%, EPS growth 79.9%, 3Y rev CAGR -60.0%
  • +86.2% vs RBOT's -94.1%
Best for: growth exposure
RBOT
Vicarious Surgical Inc.
The Growth Leader

RBOT ranks third and is worth considering specifically for growth.

  • 31.5% revenue growth vs CYN's -40.5%
Best for: growth
IROQ
IF Bancorp, Inc.
The Banking Pick

IROQ is the clearest fit if your priority is bank quality.

  • NIM 2.3% vs JPM's 2.2%
Best for: bank quality
ZVIA
Zevia PBC
The Defensive Pick

ZVIA is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.92, Low D/E 1.9%, current ratio 2.08x
  • Beta 0.92 vs LIDR's 2.51
Best for: sleep-well-at-night
KO
The Coca-Cola Company
The Quality Compounder

KO carries the broadest edge in this set and is the clearest fit for quality and dividends.

  • 27.8% margin vs LIDR's -127.0%
  • 2.5% yield, 56-year raise streak, vs JPM's 1.9%, (4 stocks pay no dividend)
  • 13.1% ROA vs RBOT's -164.5%, ROIC 15.8% vs -116.2%
Best for: quality and dividends
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 15 yrs, beta 0.94, yield 1.9%
  • 465.8% 10Y total return vs KO's 121.1%
  • PEG 0.81 vs KO's 2.26
  • Beta 0.94, yield 1.9%, current ratio 0.52x
  • Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthRBOT logoRBOT31.5% revenue growth vs CYN's -40.5%
ValueJPM logoJPMLower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
Quality / MarginsKO logoKO27.8% margin vs LIDR's -127.0%
Stability / SafetyZVIA logoZVIABeta 0.92 vs LIDR's 2.51
DividendsKO logoKO2.5% yield, 56-year raise streak, vs JPM's 1.9%, (4 stocks pay no dividend)
Momentum (1Y)LIDR logoLIDR+86.2% vs RBOT's -94.1%
Efficiency (ROA)KO logoKO13.1% ROA vs RBOT's -164.5%, ROIC 15.8% vs -116.2%

CYN vs LIDR vs RBOT vs IROQ vs ZVIA vs KO vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CYNCyngn Inc.

Segment breakdown not available.

LIDRAEye, Inc.
FY 2025
Product
67.4%$157,000
Technology Service
32.6%$76,000
RBOTVicarious Surgical Inc.

Segment breakdown not available.

IROQIF Bancorp, Inc.
FY 2025
Deposit Account
65.3%$481,000
Financial Service, Other
34.7%$256,000
ZVIAZevia PBC

Segment breakdown not available.

KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

CYN vs LIDR vs RBOT vs IROQ vs ZVIA vs KO vs JPM — Financial Metrics

Side-by-side numbers across 7 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGZVIA

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 3 of 6 comparable metrics.

JPM and RBOT operate at a comparable scale, with $280.3B and $0 in trailing revenue. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to LIDR's -127.0%. On growth, CYN holds the edge at +121.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…IROQ logoIROQIF Bancorp, Inc.ZVIA logoZVIAZevia PBCKO logoKOThe Coca-Cola Com…JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$276,397$270,000$0$48M$169M$49.3B$280.3B
EBITDAEarnings before interest/tax-$26M-$34M-$41M$7M-$5M$15.5B$81.4B
Net IncomeAfter-tax profit-$26M-$34M-$42M$5M-$7M$13.7B$57.0B
Free Cash FlowCash after capex-$27M-$29M-$40M$6M-$703,000$12.6B$100.9B
Gross MarginGross profit ÷ Revenue+34.4%-144.1%+59.5%+47.1%+61.7%+60.0%
Operating MarginEBIT ÷ Revenue-99.2%-125.8%+14.9%-3.3%+29.3%+25.9%
Net MarginNet income ÷ Revenue-94.2%-127.0%+10.8%-4.1%+27.8%+20.4%
FCF MarginFCF ÷ Revenue-97.1%-106.7%+12.4%-0.4%+25.5%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year+121.8%+57.8%+21.2%+12.1%
EPS Growth (YoY)Latest quarter vs prior year+91.1%-63.6%+58.1%+115.0%+62.5%+18.2%+16.0%
KO leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

JPM leads this category, winning 4 of 7 comparable metrics.

At 16.0x trailing earnings, JPM trades at a 41% valuation discount to KO's 27.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs KO's 2.43x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…IROQ logoIROQIF Bancorp, Inc.ZVIA logoZVIAZevia PBCKO logoKOThe Coca-Cola Com…JPM logoJPMJPMorgan Chase & …
Market CapShares × price$14M$74M$3M$89M$100M$355.6B$896.0B
Enterprise ValueMkt cap + debt − cash$19M$31M$9M$142M$75M$390.8B$1.50T
Trailing P/EPrice ÷ TTM EPS-0.24x-1.78x-0.06x19.38x-9.87x27.18x16.00x
Forward P/EPrice ÷ next-FY EPS est.25.27x14.40x
PEG RatioP/E ÷ EPS growth rate2.43x0.90x
EV / EBITDAEnterprise value multiple21.69x26.39x18.36x
Price / SalesMarket cap ÷ Revenue62.34x318.04x1.84x0.62x7.42x3.20x
Price / BookPrice ÷ Book value/share0.15x0.74x0.31x1.02x2.74x10.40x2.47x
Price / FCFMarket cap ÷ FCF13.65x67.15x8.88x
JPM leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 6 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-3 for RBOT. LIDR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), IROQ scores 7/9 vs RBOT's 1/9, reflecting strong financial health.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…IROQ logoIROQIF Bancorp, Inc.ZVIA logoZVIAZevia PBCKO logoKOThe Coca-Cola Com…JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-59.6%-56.2%-3.3%+6.2%-19.6%+41.1%+15.9%
ROA (TTM)Return on assets-48.1%-48.5%-164.5%+0.6%-11.5%+13.1%+1.3%
ROICReturn on invested capital-117.2%-100.7%-116.2%+2.9%-58.9%+15.8%+4.5%
ROCEReturn on capital employed-71.5%-64.7%-134.6%+3.9%-24.3%+17.3%+8.9%
Piotroski ScoreFundamental quality 0–93517575
Debt / EquityFinancial leverage0.18x0.00x0.79x0.89x0.02x1.33x2.60x
Net DebtTotal debt minus cash$6M-$43M$5M$53M-$25M$35.2B$599.0B
Cash & Equiv.Liquid assets$990,023$43M$3M$20M$25M$10.3B$343.3B
Total DebtShort + long-term debt$7M$235,000$8M$73M$668,000$45.5B$942.4B
Interest CoverageEBIT ÷ Interest expense-59.79x-80.57x2.72x10.70x0.74x
KO leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $0 for CYN. Over the past 12 months, LIDR leads with a +86.2% total return vs RBOT's -94.1%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs CYN's -95.5% — a key indicator of consistent wealth creation.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…IROQ logoIROQIF Bancorp, Inc.ZVIA logoZVIAZevia PBCKO logoKOThe Coca-Cola Com…JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date-54.9%-24.2%-79.8%-1.6%-26.4%+20.3%-0.5%
1-Year ReturnPast 12 months-72.6%+86.2%-94.1%+11.1%-48.6%+17.2%+21.8%
3-Year ReturnCumulative with dividends-100.0%-70.4%-99.2%+99.9%-68.3%+47.0%+138.2%
5-Year ReturnCumulative with dividends-100.0%-99.5%-99.8%+25.4%-89.2%+65.6%+118.2%
10-Year ReturnCumulative with dividends-100.0%-99.5%-99.8%+60.1%-89.2%+121.1%+465.8%
CAGR (3Y)Annualised 3-year return-95.5%-33.4%-80.0%+26.0%-31.8%+13.7%+33.6%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

KO leads this category, winning 2 of 2 comparable metrics.

KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than LIDR's 2.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs CYN's 3.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…IROQ logoIROQIF Bancorp, Inc.ZVIA logoZVIAZevia PBCKO logoKOThe Coca-Cola Com…JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5002.18x2.51x2.42x-0.05x0.92x-0.20x0.94x
52-Week HighHighest price in past year$41.54$6.44$13.75$29.00$3.66$84.04$337.25
52-Week LowLowest price in past year$1.22$0.71$0.35$23.21$1.11$65.35$262.71
% of 52W HighCurrent price vs 52-week peak+3.0%+24.8%+3.7%+91.6%+40.4%+98.3%+95.1%
RSI (14)Momentum oscillator 0–10036.036.736.534.447.660.659.1
Avg Volume (50D)Average daily shares traded277K3.4M14K103K761K12.7M7.0M
KO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

KO leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: LIDR as "Hold", ZVIA as "Buy", KO as "Buy", JPM as "Buy". Consensus price targets imply 650.0% upside for LIDR (target: $12) vs 4.2% for KO (target: $86). For income investors, KO offers the higher dividend yield at 2.46% vs IROQ's 1.54%.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…IROQ logoIROQIF Bancorp, Inc.ZVIA logoZVIAZevia PBCKO logoKOThe Coca-Cola Com…JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuy
Price TargetConsensus 12-month target$12.00$3.50$86.13$339.75
# AnalystsCovering analysts484861
Dividend YieldAnnual dividend ÷ price+1.5%+2.5%+1.9%
Dividend StreakConsecutive years of raises2015615
Dividend / ShareAnnual DPS$0.41$2.04$5.95
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%0.0%0.0%+0.2%+3.9%
KO leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

KO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). JPM leads in 2 (Valuation Metrics, Total Returns).

Best OverallThe Coca-Cola Company (KO)Leads 4 of 6 categories
Loading custom metrics...

CYN vs LIDR vs RBOT vs IROQ vs ZVIA vs KO vs JPM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CYN or LIDR or RBOT or IROQ or ZVIA or KO or JPM a better buy right now?

For growth investors, AEye, Inc.

(LIDR) is the stronger pick with 15. 3% revenue growth year-over-year, versus -40. 5% for Cyngn Inc. (CYN). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Zevia PBC (ZVIA) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CYN or LIDR or RBOT or IROQ or ZVIA or KO or JPM?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 0x versus The Coca-Cola Company at 27. 2x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus The Coca-Cola Company's 2. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — CYN or LIDR or RBOT or IROQ or ZVIA or KO or JPM?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -100. 0% for Cyngn Inc. (CYN). Over 10 years, the gap is even starker: JPM returned +465. 8% versus CYN's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CYN or LIDR or RBOT or IROQ or ZVIA or KO or JPM?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

20β versus AEye, Inc. 's 2. 51β — meaning LIDR is approximately -1353% more volatile than KO relative to the S&P 500. On balance sheet safety, AEye, Inc. (LIDR) carries a lower debt/equity ratio of 0% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CYN or LIDR or RBOT or IROQ or ZVIA or KO or JPM?

By revenue growth (latest reported year), AEye, Inc.

(LIDR) is pulling ahead at 15. 3% versus -40. 5% for Cyngn Inc. (CYN). On earnings-per-share growth, the picture is similar: IF Bancorp, Inc. grew EPS 140. 4% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Over a 3-year CAGR, KO leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CYN or LIDR or RBOT or IROQ or ZVIA or KO or JPM?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -145. 7% for AEye, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -136. 2% for LIDR. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CYN or LIDR or RBOT or IROQ or ZVIA or KO or JPM more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus The Coca-Cola Company's 2. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 25. 3x for The Coca-Cola Company — 10. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIDR: 650. 0% to $12. 00.

08

Which pays a better dividend — CYN or LIDR or RBOT or IROQ or ZVIA or KO or JPM?

In this comparison, KO (2.

5% yield), JPM (1. 9% yield), IROQ (1. 5% yield) pay a dividend. CYN, LIDR, RBOT, ZVIA do not pay a meaningful dividend and should not be held primarily for income.

09

Is CYN or LIDR or RBOT or IROQ or ZVIA or KO or JPM better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

20), 2. 5% yield, +121. 1% 10Y return). Cyngn Inc. (CYN) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +121. 1%, CYN: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CYN and LIDR and RBOT and IROQ and ZVIA and KO and JPM?

These companies operate in different sectors (CYN (Technology) and LIDR (Consumer Cyclical) and RBOT (Healthcare) and IROQ (Financial Services) and ZVIA (Consumer Defensive) and KO (Consumer Defensive) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CYN is a small-cap quality compounder stock; LIDR is a small-cap high-growth stock; RBOT is a small-cap quality compounder stock; IROQ is a small-cap quality compounder stock; ZVIA is a small-cap quality compounder stock; KO is a large-cap quality compounder stock; JPM is a large-cap deep-value stock. IROQ, KO, JPM pay a dividend while CYN, LIDR, RBOT, ZVIA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.